Pregled bibliografske jedinice broj: 197759
Effects of acute and subacute treatment with ergot drugs on the GABA system in specific brain regions
Effects of acute and subacute treatment with ergot drugs on the GABA system in specific brain regions // Journal of pharmacy and pharmacology, 33 (1981), 1; 655-659 doi:10.1111/j.2042-7158.1981.tb13893.x (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 197759 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Effects of acute and subacute treatment with ergot drugs on the GABA system in specific brain regions
Autori
Peričić, Danka
Izvornik
Journal of pharmacy and pharmacology (0022-3573) 33
(1981), 1;
655-659
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
dihydroergotoxine ; dihydroergotamine ; GABA levels and turnover ; GAD ; brain regions
Sažetak
The effect of dihydroergotoxine and dihydroergotamine on gamma-aminobutyric acid (GABA) levels, the aminooxyacetic acid (AOAA)-induced accumulation of GABA, and the in vitro activity of L-glutamate decarboxylase (GAD) have been examined in various regions of rat brain. Dihydroergotoxine (1 mg kg-1) decreased the concentration of GABA and enhanced the AOAA-induced accumulation of GABA in the caudate nucleus and cingulate cortex. Dihydroergotoxine 10.0 mg kg-1 decreased the AOAA-induced accumulation of GABA in the substantia nigra. The repeated treatment with dihydroergotoxine, 0.05 mg kg-1 for eight days, also decreased the concentration of GABA in the cingulate cortex and diminished the AOAA-induced accumulation of GABA in the substantia nigra. The administration of 0.1 mg kg-1, but not higher doses ; of dihydroergotamine, enhanced the AOAA-induced accumulation of GABA in the cingulate cortex. Dihydroergotamine (10.0 mg kg-1) decreased the concentration of GABA in the cingulate cortex and increased the AOAA-induced accumulation of GABA in the caudate nucleus. The activity of GAD in the cingulate cortex, but not in the caudate nucleus, was enhanced after a high dose of dihydroergotamine. Observed increases in the AOAA-induced accumulation of GABA indicate that dihydroergotoxine and dihydroergotamine in at least some brain areas cause an apparent increase in GABA synthesis in vivo, which is presumably a compensatory phenomenon due to a diminished GABAergic transmission under the influence of these drugs.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica
- Index Medicus